Charles Sternberg, Associate Editor07.29.22
Promimic AB and Danco Medical, a Lincotek Group Company, have formed a joint venture focused on the processing of HAnano Surface for medical implants in the U.S. market.
The new company will be called Nano Processing Inc. (NPI) and will ramp up the use of the unique HAnano Surface technology, which improves osseointegration of orthopedic and dental implants.
The launch of the joint venture is a response to the rapid change in a fast-growing market segment and the needs in the market for a qualified and well-respected service provider.
“This joint venture was made possible through the Promimic IPO in April, and will have a major impact on our growth potential, especially for 2023 and onwards, enabling us to serve our customers more efficiently,” he continues.
NPI is built around Promimic’s core technology, HAnano Surface. The partnership has provided for rapid growth in recent years, and this unique surface treatment technology is now in clinical use across several orthopedic specialties – from spinal fusion to total knee replacement.
The day-to-day operations will be managed and executed by Danco Medical, while leveraging Promimic’s deep knowledge in nanotechnologies and US-based sales channel for business growth with both existing and new customers.
“We are delighted to develop the partnership with Promimic further. Together we stand strong to capture growing business opportunities we see today and expand this business substantially long-term,” says Tim Zentz, general manager of Danco Medical.
Promimic’s business model is based on licensing HAnano Surface to leading implant companies in the orthopedic and dental fields. NPI will broaden Promimic’s service to include upstream capabilities close to the customers together with a well-established and recognized player in the USA market– Danco Medical.
The new company will be called Nano Processing Inc. (NPI) and will ramp up the use of the unique HAnano Surface technology, which improves osseointegration of orthopedic and dental implants.
The launch of the joint venture is a response to the rapid change in a fast-growing market segment and the needs in the market for a qualified and well-respected service provider.
About the Joint Venture
“The creation of Nano Processing, Inc. broadens our business model and is a key initiative in our growth strategy. We are pleased to share this important milestone with the Danco Medical team, as a natural progression of a great partnership,” says Magnus Larsson, CEO at Promimic.“This joint venture was made possible through the Promimic IPO in April, and will have a major impact on our growth potential, especially for 2023 and onwards, enabling us to serve our customers more efficiently,” he continues.
NPI is built around Promimic’s core technology, HAnano Surface. The partnership has provided for rapid growth in recent years, and this unique surface treatment technology is now in clinical use across several orthopedic specialties – from spinal fusion to total knee replacement.
The day-to-day operations will be managed and executed by Danco Medical, while leveraging Promimic’s deep knowledge in nanotechnologies and US-based sales channel for business growth with both existing and new customers.
“We are delighted to develop the partnership with Promimic further. Together we stand strong to capture growing business opportunities we see today and expand this business substantially long-term,” says Tim Zentz, general manager of Danco Medical.
Promimic’s business model is based on licensing HAnano Surface to leading implant companies in the orthopedic and dental fields. NPI will broaden Promimic’s service to include upstream capabilities close to the customers together with a well-established and recognized player in the USA market– Danco Medical.
